Why Oncologists Are Prescribing GLP-1s
Why Oncologists Are Prescribing GLP-1s

Why Oncologists Are Prescribing GLP-1s

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

Given the increasing prevalence of weight-related conditions and the rapid uptake of GLP-1s on the one hand, and the increasing incidence of cancer on the other hand, it was inevitable that these two worlds would collide. In this paper, we uncover what's really happening at the intersection of two of healthcare's most defining challenges.

Improved patient outcomes, reduced treatment toxicity, enhanced drug efficacy – oncologists are finding compelling reasons to reach for GLP-1s. But concerns around drug interactions and unclear long-term effects reveal a more complex picture.

This essential read provides evidence-based understanding of why cancer specialists are embracing – and sometimes avoiding – this rapidly expanding drug class, and what clarity the industry needs to provide.

Why Oncologists Are Prescribing GLP-1s

Why Oncologists Are Prescribing GLP-1s

Explore the Findings

Related news

  • [WEBINAR] What the Future: Success
    Consumer Behavior Events replay

    [WEBINAR] What the Future: Success

    Hear more about the modern milestones for success and how brand leaders across industry and public policy can adapt now with a deeper understanding of today’s consumer.
  • [WEBINAR] Accelerating Innovation Development with Synthetic Data
    Society Webinar

    [WEBINAR] Accelerating Innovation Development with Synthetic Data

    Join Ipsos for a discussion of how synthetic data approaches to AI can be used with concept and product testing to reduce speed to market while producing better results.
  • The Business of Naming
    Market Research Event

    The Business of Naming

    From creating community to staying creative (and competitive) to running the business of it all, The Business of Naming conference is where namers find what it takes to get ahead. Join us for a packed of talks, panels, and quality time alongside the best and brightest in naming.